Follow
Rong Lu
Rong Lu
School of Medicine, Stanford University
Verified email at stanford.edu - Homepage
Title
Cited by
Cited by
Year
Immune dysregulation in cancer patients developing immune-related adverse events
S Khan, SA Khan, X Luo, FJ Fattah, J Saltarski, Y Gloria-McCutchen, R Lu, ...
British journal of cancer 120 (1), 63-68, 2019
1612019
An empirical approach leveraging tumorgrafts to dissect the tumor microenvironment in renal cell carcinoma identifies missing link to prognostic inflammatory factors
T Wang, R Lu, P Kapur, BS Jaiswal, R Hannan, Z Zhang, I Pedrosa, ...
Cancer discovery 8 (9), 1142-1155, 2018
1532018
Variation in the assessment of immune-related adverse event occurrence, grade, and timing in patients receiving immune checkpoint inhibitors
D Hsiehchen, MK Watters, R Lu, Y Xie, DE Gerber
JAMA network open 2 (9), e1911519-e1911519, 2019
662019
Artificial intelligence enables whole-body positron emission tomography scans with minimal radiation exposure
YR Wang, L Baratto, KE Hawk, AJ Theruvath, A Pribnow, AS Thakor, ...
European journal of nuclear medicine and molecular imaging 48, 2771-2781, 2021
612021
Identifying Factors Associated with Head Impact Kinematics and Brain Strain in High School American Football via Instrumented Mouthguards
NJ Cecchi, AG Domel, Y Liu, E Rice, R Lu, X Zhan, Z Zhou, SJ Raymond, ...
Annals of biomedical engineering 49, 2814-2826, 2021
432021
Incidence of interstitial lung disease in patients with rheumatoid arthritis treated with biologic and targeted synthetic disease-modifying antirheumatic drugs
MC Baker, Y Liu, R Lu, J Lin, J Melehani, WH Robinson
JAMA Network Open 6 (3), e233640-e233640, 2023
302023
Ligand-free estrogen receptor α (ESR1) as master regulator for the expression of CYP3A4 and other cytochrome P450 enzymes in the human liver
D Wang, R Lu, G Rempala, W Sadee
Molecular pharmacology 96 (4), 430-440, 2019
282019
Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors
MS von Itzstein, AS Gonugunta, Y Wang, T Sheffield, R Lu, S Ali, FJ Fattah, ...
Cancer Immunology, Immunotherapy 71 (9), 2169-2181, 2022
222022
Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon
S Khan, MS von Itzstein, R Lu, BL Bermas, DR Karp, SA Khan, FJ Fattah, ...
The Oncologist 25 (5), e753-e757, 2020
212020
Estimation of Sobol's sensitivity indices under generalized linear models
R Lu, D Wang, M Wang, GA Rempala
Communications in Statistics-Theory and Methods 47 (21), 5163-5195, 2018
212018
Mobile device applications for electronic patient portals in oncology
KK Pho, R Lu, S Gates, J Cai, D Xie, Y Xie, SJC Lee, DE Gerber
JCO clinical cancer informatics 3, 1-8, 2019
202019
Increased risk of osteoarthritis in patients with atopic disease
MC Baker, K Sheth, R Lu, D Lu, EP von Kaeppler, A Bhat, DT Felson, ...
Annals of the rheumatic diseases 82 (6), 866-872, 2023
182023
Characteristics of patients using patient portals in oncology
K Pho, R Lu, S Gates, Y Xie, SJC Lee, DE Gerber
JAMA oncology 4 (3), 416-418, 2018
182018
Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation
EC Liang, C Chen, R Lu, GN Mannis, L Muffly
Blood 138, 1306, 2021
142021
Development and validation of a nomogram prognostic model for patients with advanced non-small-cell lung cancer
T Wang, R Lu, S Lai, JH Schiller, FL Zhou, B Ci, S Wang, X Gao, B Yao, ...
Cancer informatics 18, 1176935119837547, 2019
142019
Development of osteoarthritis in adults with type 2 diabetes treated with metformin vs a sulfonylurea
MC Baker, K Sheth, Y Liu, D Lu, R Lu, WH Robinson
JAMA Network Open 6 (3), e233646-e233646, 2023
132023
Diagnostic Accuracy of 2-[18F]FDG-PET and whole-body DW-MRI for the detection of bone marrow metastases in children and young adults
A Rashidi, L Baratto, AJ Theruvath, EB Greene, KE Hawk, R Lu, MP Link, ...
European radiology 32 (7), 4967-4979, 2022
132022
Closing the gap: Contribution of surgical best practices to outcome differences between high‐and low‐volume centers for lung cancer resection
MS von Itzstein, R Lu, KH Kernstine, EA Halm, S Wang, Y Xie, DE Gerber
Cancer Medicine 9 (12), 4137-4147, 2020
122020
Analyzing allele specific RNA expression using mixture models
R Lu, RM Smith, M Seweryn, D Wang, K Hartmann, A Webb, W Sadee, ...
BMC genomics 16, 1-11, 2015
122015
Statin Intolerance, Anti‐HMGCR Antibodies, and Immune Checkpoint Inhibitor‐Associated Myositis: A “Two‐Hit” Autoimmune Toxicity or Clinical Predisposition?
MS von Itzstein, S Khan, V Popat, R Lu, SA Khan, FJ Fattah, JY Park, ...
The oncologist 25 (8), e1242-e1245, 2020
112020
The system can't perform the operation now. Try again later.
Articles 1–20